DOPE-GA

• Description:

  DOPE-GA can be used in the preparation of liposomes for research on drug delivery and other applications[1][2].

• UNSPSC:

  12352211

• Target:

  Liposome

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/dope-ga.html

• Purity:

  98.0

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  OC(CCCC(NCCOP(OC[C@@H](COC(CCCCCCC/C=C\CCCCCCCC)=O)OC(CCCCCCC/C=C\CCCCCCCC)=O)(O)=O)=O)=O

• Molecular Formula:

  C46H84NO11P

• Molecular Weight:

  858.13

• References & Citations:

  [1]Cuvillier O, et al. Liposomal ET-18-OCH (3) induces cytochrome c-mediated apoptosis independently of CD95 (APO-1/Fas) signaling. Blood. 1999 Nov 15;94 (10) :3583-92. |[2]Perkins WR, et al. Novel therapeutic nano-particles (lipocores) : trapping poorly water soluble compounds. Int J Pharm. 2000 Apr 25;200 (1) :27-39.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [228706-30-7]